Roma (Ovarian Malignancy)
ROMA is a blood test used to assess the likelihood of ovarian cancer in women with an adnexal mass. It combines CA125 and HE4 markers to help predict cancer risk.
- Human Epididymis Protein-4, Serum
- Ca 125, Serum
- Risk Of Ovarian Malignancy Algorithm
The Risk of Ovarian Malignancy Algorithm (ROMA) combines HE4 and CA125 markers to assess the likelihood of ovarian cancer in women with pelvic masses.
It is recommended for postmenopausal and premenopausal women with ovarian cysts or suspected ovarian cancer.
A blood sample is analyzed using immunoassays to measure HE4 and CA125 levels, and the ROMA score is calculated based on menopausal status.
- High ROMA score: Indicates increased risk of ovarian malignancy.
- Low ROMA score: Suggests a benign mass or low likelihood of cancer.
No, the ROMA test is a risk assessment tool and should be used alongside imaging and biopsy for definitive diagnosis.
Test code
7194
CPT and Loinc codes
Department
- Eia-endocrinology
Turn around time
Same Day
Test run frequency
Monday,Thursday TIME - 15:30
Performing locations
5 labs across India
Specimen vol. and vacutainer information
| Specimen | Vacutainer | Volume |
|---|---|---|
| Serum | Yellow Vacutainer | 2 ML |
| Swab | Others | 9 NO |
Specimen stability information
Serum
Package price
₹3650
Need Help?
Talk to our health experts for guidance on tests, reports, or bookings.
WhatsApp to Book TestRoma (Ovarian Malignancy)
₹3650